MRANK-103

N/A

Report date: 2024/09/20 09:28:15
NME

Base Information

Drug NameMRANK-103
Drug Alias NameMRANK-103MRANK-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein modulators
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMindRank Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMindRank Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A